FI955429L - 1-aryylisykloalkyylisulfideja, sulfoksideja ja sulfoneja depression, tuskatilojen ja Parkinsonin taudin hoitamiseksi - Google Patents
1-aryylisykloalkyylisulfideja, sulfoksideja ja sulfoneja depression, tuskatilojen ja Parkinsonin taudin hoitamiseksi Download PDFInfo
- Publication number
- FI955429L FI955429L FI955429A FI955429A FI955429L FI 955429 L FI955429 L FI 955429L FI 955429 A FI955429 A FI 955429A FI 955429 A FI955429 A FI 955429A FI 955429 L FI955429 L FI 955429L
- Authority
- FI
- Finland
- Prior art keywords
- arylcycloalkyl
- sulfoxides
- sulfones
- sulfides
- parkinson
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939309749A GB9309749D0 (en) | 1993-05-12 | 1993-05-12 | Therapeutic agents |
| PCT/EP1994/001494 WO1994026704A1 (en) | 1993-05-12 | 1994-05-07 | 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI955429A0 FI955429A0 (fi) | 1995-11-10 |
| FI955429A7 FI955429A7 (fi) | 1996-01-03 |
| FI955429L true FI955429L (fi) | 1996-01-03 |
Family
ID=10735317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI955429A FI955429L (fi) | 1993-05-12 | 1994-05-07 | 1-aryylisykloalkyylisulfideja, sulfoksideja ja sulfoneja depression, tuskatilojen ja Parkinsonin taudin hoitamiseksi |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5652271A (cs) |
| EP (1) | EP0715620B1 (cs) |
| JP (2) | JP3606326B2 (cs) |
| KR (1) | KR100295264B1 (cs) |
| AT (1) | ATE172719T1 (cs) |
| AU (1) | AU681669B2 (cs) |
| BG (1) | BG61913B1 (cs) |
| BR (2) | BR9406577A (cs) |
| CZ (1) | CZ290711B6 (cs) |
| DE (1) | DE69414264T2 (cs) |
| DK (1) | DK0715620T3 (cs) |
| ES (1) | ES2124411T3 (cs) |
| FI (1) | FI955429L (cs) |
| GB (1) | GB9309749D0 (cs) |
| HU (1) | HU211124A9 (cs) |
| IL (1) | IL109635A (cs) |
| LV (1) | LV11320A (cs) |
| MY (1) | MY110773A (cs) |
| NO (1) | NO305165B1 (cs) |
| NZ (1) | NZ266776A (cs) |
| PH (1) | PH30418A (cs) |
| PL (1) | PL176400B1 (cs) |
| RO (1) | RO115519B1 (cs) |
| RU (1) | RU2135467C1 (cs) |
| SK (1) | SK281257B6 (cs) |
| TW (1) | TW318833B (cs) |
| UA (1) | UA42722C2 (cs) |
| WO (1) | WO1994026704A1 (cs) |
| ZA (1) | ZA943241B (cs) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19518988A1 (de) * | 1995-05-29 | 1996-12-05 | Basf Ag | Verwendung arylsubstituierter Cyclobutylalkylamine zur Behandlung der Fettleibigkeit |
| GB9524681D0 (en) | 1995-12-02 | 1996-01-31 | Knoll Ag | Chemical process |
| GB9915617D0 (en) | 1999-07-05 | 1999-09-01 | Knoll Ag | Therapeutic agents |
| US20040166159A1 (en) * | 2002-05-29 | 2004-08-26 | Chien-Hsuan Han | Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa |
| US20060013875A1 (en) * | 2002-05-29 | 2006-01-19 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
| US20030224045A1 (en) * | 2002-05-29 | 2003-12-04 | Chien-Hsuan Han | Combination immediate release sustained release levodopa/carbidopa dosage forms |
| US7094427B2 (en) * | 2002-05-29 | 2006-08-22 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
| US20090093453A1 (en) * | 2006-04-26 | 2009-04-09 | Toyama Chemical Co., Ltd | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| EP3782614A1 (en) | 2013-10-07 | 2021-02-24 | Impax Laboratories, LLC | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
| US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
| EP4267113A4 (en) | 2020-12-22 | 2025-02-12 | Amneal Pharmaceuticals LLC | LEVODOPA DOSING SCHEME |
| US11986449B2 (en) | 2020-12-22 | 2024-05-21 | Amneal Pharmaceuticals Llc | Levodopa dosing regimen |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE52768B1 (en) * | 1981-04-06 | 1988-02-17 | Boots Co Ltd | 1-arylcyclobutylalkylamine compounds useful as therapeutic agents |
| IE56000B1 (en) * | 1982-09-30 | 1991-03-13 | Boots Co Plc | 1-arylcyclobutylalkylamine compounds |
| IE56001B1 (en) * | 1982-09-30 | 1991-03-13 | Boots Co Plc | 1-arylcyclobutylmethylamine compounds |
| GB8501192D0 (en) * | 1985-01-17 | 1985-02-20 | Boots Co Plc | Therapeutic agents |
| CH664957A5 (de) * | 1985-09-24 | 1988-04-15 | Lonza Ag | Verfahren zur herstellung von 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamid. |
| GB8704777D0 (en) * | 1987-02-28 | 1987-04-01 | Boots Co Plc | Medical treatment |
-
1993
- 1993-05-12 GB GB939309749A patent/GB9309749D0/en active Pending
-
1994
- 1994-05-07 SK SK1407-95A patent/SK281257B6/sk not_active IP Right Cessation
- 1994-05-07 CZ CZ19952936A patent/CZ290711B6/cs not_active IP Right Cessation
- 1994-05-07 NZ NZ266776A patent/NZ266776A/en not_active IP Right Cessation
- 1994-05-07 FI FI955429A patent/FI955429L/fi unknown
- 1994-05-07 DE DE69414264T patent/DE69414264T2/de not_active Expired - Lifetime
- 1994-05-07 AT AT94916944T patent/ATE172719T1/de active
- 1994-05-07 WO PCT/EP1994/001494 patent/WO1994026704A1/en active IP Right Grant
- 1994-05-07 BR BR9406577A patent/BR9406577A/pt not_active Application Discontinuation
- 1994-05-07 EP EP94916944A patent/EP0715620B1/en not_active Expired - Lifetime
- 1994-05-07 KR KR1019950705037A patent/KR100295264B1/ko not_active Expired - Lifetime
- 1994-05-07 AU AU68433/94A patent/AU681669B2/en not_active Expired
- 1994-05-07 DK DK94916944T patent/DK0715620T3/da active
- 1994-05-07 JP JP52494694A patent/JP3606326B2/ja not_active Expired - Lifetime
- 1994-05-07 US US08/545,752 patent/US5652271A/en not_active Expired - Lifetime
- 1994-05-07 RU RU95122740A patent/RU2135467C1/ru active
- 1994-05-07 UA UA95114926A patent/UA42722C2/uk unknown
- 1994-05-07 PL PL94311628A patent/PL176400B1/pl unknown
- 1994-05-07 RO RO95-01958A patent/RO115519B1/ro unknown
- 1994-05-07 ES ES94916944T patent/ES2124411T3/es not_active Expired - Lifetime
- 1994-05-11 ZA ZA943241A patent/ZA943241B/xx unknown
- 1994-05-12 IL IL109635A patent/IL109635A/en not_active IP Right Cessation
- 1994-05-12 PH PH48262A patent/PH30418A/en unknown
- 1994-05-12 MY MYPI94001186A patent/MY110773A/en unknown
- 1994-11-11 TW TW083110470A patent/TW318833B/zh active
-
1995
- 1995-06-30 HU HU95P/P00686P patent/HU211124A9/hu unknown
- 1995-11-10 NO NO954542A patent/NO305165B1/no not_active IP Right Cessation
- 1995-11-10 BG BG100127A patent/BG61913B1/bg unknown
- 1995-12-11 LV LV950366A patent/LV11320A/xx unknown
-
1997
- 1997-04-22 BR BR1100306-5A patent/BR1100306A/pt active IP Right Grant
-
2004
- 2004-06-16 JP JP2004178477A patent/JP2004331669A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2018020I2 (el) | Θεραπεια της νοσου ρομρε | |
| AU674894B2 (en) | Treatment of conditions and disease | |
| PT861081E (pt) | Utilizacao de epinastina para o tratamento de dores | |
| GR980300033T1 (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
| FI20000720A7 (fi) | Pitkitettyyn vapautumiseen perustuva tablettiformulaatio Parkisonin taudin hoitamiseksi | |
| EP0331620A3 (en) | Agent for the treatment of parkinson's disease | |
| IL164839A0 (en) | Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas | |
| FI955429L (fi) | 1-aryylisykloalkyylisulfideja, sulfoksideja ja sulfoneja depression, tuskatilojen ja Parkinsonin taudin hoitamiseksi | |
| AU2466695A (en) | The use of famotidine and related compounds in the treatment of movement disorders | |
| AU2463099A (en) | Gabapentin and its derivatives for the treatment of muscular and skeletal pain | |
| BR9403574A (pt) | Articulação de três ramos com fixação de rolos | |
| AU4131296A (en) | Treatment of disorders with duloxetine | |
| IT9041529A0 (it) | Dispositivo per la correzione chirurgica dell'ametropia | |
| IL129144A0 (en) | Use of 1-hydroxy-2-pyridones for the treatment of skin diseases | |
| HUP0000785A3 (en) | Ointment for the treatment of burns and other skin diseases | |
| IT1288399B1 (it) | Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi | |
| NO982562D0 (no) | Sammensetning for behandling av smerte | |
| AU7622798A (en) | Application of thalidomide to the treatment of Parkinson's disease and Parkisonian syndromes | |
| AU6678194A (en) | Agents for the prevention and treatment of huntington's disease and other neurological disorders | |
| FI952953L (fi) | Aineita metabolisten luustosairauksien hoitamiseen | |
| IL133398A0 (en) | (s) 2-methylamino-2-phenyl - n-butyl 3,4,5 - trimethoxybenzoate and its application to the treatment of chronic pain | |
| AU2137595A (en) | Use of arylpiperazine derivatives for the treatment of Parkinson's disease and psychosis | |
| ITRM970235A0 (it) | Catetere per la diagnosi e il trattamento dell'eiaculazione precoce | |
| SE8802323D0 (sv) | 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
| HU9700079D0 (en) | Topical compositions for the treatment of skin disease |